Theravance Biopharma Inc. (TBPH)

TBPH trades at $13.41, 34.1% above the near-term max pain of $10 expiring Sep 19, 2025 (31 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$12.5), signaling increased put positioning or downside protection. Key magnetic zone at 10 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for TBPH shows a downward trend from 12.5 to 2.5, indicating bearish sentiment or hedging activity. The 114% spread signals divergent expectations across timeframes. Most levels below 13.41 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.